PTCT
PTCT
NASDAQ · Biotechnology

Ptc Therapeutics Inc

Mid-Cap Stocks Biotech Stocks Healthcare Stocks
$64.54
-1.88 (-2.83%)
As of Mar 24, 9:50 PM ET ·
Analyst Consensus
Buy
22
Analysts
High
Coverage
Buy 16 73%
Hold 5 23%
Sell 1 5%
Price Target
Analyst Price Target +20.8% upside
Low Target $54.55
Average Target $77.98
High Target $125.35
Current Price $64.54
Current
$64.54
Target
$77.98
$54.55 $77.98 avg $125.35
Scenario Analysis
Bear Case
$54.55
-15.5%
Low target
Base Case
$77.98
+20.8%
Avg target
Bull Case
$125.35
+94.2%
High target
Risk/Reward
6.1x
Highly favorable
Price in Context
52-Week High
$87.50
-26.2% from high
52-Week Low
$35.95
+79.5% from low
50-Day SMA
$75.08
-14.0% vs SMA
200-Day SMA
$61.55
+4.9% vs SMA
RSI (14)
25.1
Oversold
Target vs 52W High
$77.98
-10.9% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
 Buy 39 69% $257.58 +25.5%
AMGN
Amgen Inc
 Hold 42 50% $190.87 -45.2%
GILD
Gilead Sciences Inc
 Strong Buy 37 81% $362.68 +162.6%
VRTX
Vertex Pharmaceuticals Inc
 Strong Buy 39 79% $438.34 -2.3%
REGN
Regeneron Pharmaceuticals
 Strong Buy 36 75% $76.80 -89.6%
ALNY
Alnylam Pharmaceuticals Inc
 Strong Buy 36 78% $102.31 -66.8%
INSM
Insmed Inc
 Strong Buy 26 92% $143.40 +3.1%
NTRA
Natera Inc
 Strong Buy 27 89% $142.91 -26.5%